Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5562 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 9 10 11 ... 54 55 56  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Provecs–Akampion: public relations, 201710 service existent by Akampion 2017-10-26
Tesaro–Evotec: drug discovery services, 201710– collab 3y €na r+d small-molecule candidates against I/O target 2017-10-26
JnJ–BioMed X: pharma research, 201710– collab up to five research projects in area of autoimmune disease w Janssen RnD LLC 2017-10-25
Fluidigm–Univ Zurich: mass cytometry s/w, 201710– ww distribution of histoCAT s/w with Hyperion Imaging System by Fluidigm 2017-10-24
ADC Therapeutics–SEVERAL: investment, 201710 private financing round $200m incl Auven Therapeutics + Wild Family Office + AstraZeneca 2017-10-23
Counsyl–Qiagen: genomic software tools, 201710 supply existent early customer of Qiagen Clinical Insight solution 2017-10-19
DCPrime–Apceth: contract manufacturing, 201710– supply service manufacturing of DCP-001 DC vaccine by Apceth Biopharma GmbH 2017-10-19
High-Tech Gründerfonds–RWE: investment, 201710 investment 7-digit € of RWE Generation SE in HTGF III Fund 2017-10-19
CureVac–Lilly: investment, 201710 equity investment $45m as part of mRNA cancer vaccines collaboration 2017-10-18
Lilly–CureVac: cancer vaccines, 201710– collab ww $50m upfront + $45m equity investment + $1.7b milestones up to 5 products using RNActive technology 2017-10-18
SurgVision–Bracco: investment, 201710 acquisition of SurgVision BV by Bracco Imaging SpA 2017-10-18
Weizmann Institute–Bruker Corp: MRI system, 201710 supply Biospec 15.2 Tesla USR preclinical UHF MRI system 2017-10-18
Institut Nehring–Eurofins: investment, 201710 acquisition of Institut Nehring GmbH by Eurofins 2017-10-16
Roche–Warp Drive Bio: drug discovery, 201710– strategic collab up to $387m plus royalties r+d of novel antibiotics using Genome Mining platform 2017-10-16
Apeiron–MC Services: public relations, 201710 service existent by MC Services AG 2017-10-13
InflaRx–Bain Capital: investment, 201710 financing round Series D totalling $30m incl co-lead investor Bain Capital Life Sciences LP 2017-10-13
InflaRx–Cormorant Asset Management: investment, 201710 financing round Series D totalling $30m incl co-lead investor Cormorant 2017-10-13
InflaRx–RA Capital Management: investment, 201710 financing round Series D totalling $30m incl co-lead investor RA Capital Management LLC 2017-10-13
InflaRx–SEVERAL: investment, 201710 financing round Series D $55m capital increase co-led by Bain Capital LS + Cormorant + RA Capital 2017-10-13
Kohlberg Kravis Roberts–Eurofins: investment, 201710– acquisition of LGC Forensics division of LGC Group from KKR 2017-10-12
Nestlé–Codexis: therapeutic enzymes, 201710– collab strategic alliance using CodeEvolver platform + incl option for ww developm of CDX-6114 2017-10-12
BIA Separations–Nuvonis: vaccine + gene therapy production technology, 201710– collab co-marketing of cell lines + purification technologies 2017-10-10
Bruker Corp–Protea Biosciences: MS-based clinical tests, 201710– collab development clinical oncology screening assays on rapifleX MALDI Tissuetyper 2017-10-10
Medical Univ Innsbruck–Helmholtz: IP services, 201710– service collab knowledge + technology transfer with Ascenion GmbH 2017-10-09
Chiome Bioscience–Minapharm: GlymaxX technology, 201710– service + license cell line developm for antibody production applying GlymaxX by ProBioGen 2017-10-05
Boehringer–Siamab Therapeutics: antibody cancer drug, 201710– collab €na discovery of TACA selective targeting antibodies 2017-10-04
Immatics–Amgen: investment, 201710 financing round Series E totalling $58m incl Hopp + Strüngmann + Wellington Partners + Amgen et al 2017-10-04
Immatics–Hopp Group: investment, 201710 financing round Series E totalling $58m incl Hopp + Strüngmann + Wellington Partners + Amgen et al 2017-10-04
Immatics–SEVERAL: investment, 201710 financing round Series E $58m Hopp + Strüngmann + Wellington Partners + Amgen et al 2017-10-04
Immatics–Strüngmann Group: investment, 201710 financing round Series E totalling $58m incl Hopp + Strüngmann + Wellington Partners + Amgen et al 2017-10-04
Immatics–Wellington Partners: investment, 201710 financing round Series E totalling $58m incl Hopp + Strüngmann + Wellington Partners + Amgen et al 2017-10-04
Lunaphore–Redalpine: investment, 201710 2nd financing round totalling CHF6m incl existing investor Redalpine Venture Partners 2017-10-04
Lunaphore–SEVERAL: investment, 201710 2nd financing round CHF6m incl Redalpine + Zühlke Ventures + Polytech Ecosystem et al. 2017-10-04
Body Labs–Amazon: investment, 201710 acquisition €na (estimate $50m–$70m) of Body Labs by Amazon 2017-10-03
Cullinan Oncology–F2 Ventures: investment, 201710 financing round Series A totalling $150m incl co-lead investor F2 Ventures 2017-10-03
Cullinan Oncology–SEVERAL: investment, 201710 financing round Series A $150m co-led by UBS Oncology Impact Fund (MPM Capital) + F2 Ventures 2017-10-03
Cullinan Oncology–UBS: investment, 201710 financing round Series A totalling $150m incl co-lead investor UBS Oncology Impact Fund managed by MPM 2017-10-03
Epiontis–Precision Medicine Group: investment, 201709 acquistion of Epiontis GmbH 2017-09-30
Eppendorf–Arburg: plastic moulding machine, 201709 supply of 100th Allrounder machine to Eppendorf Polymere GmbH 2017-09-29
Exscientia–Evotec: investment, 201709 investment €15m by Evotec AG to acquire minority stake in Exscientia Ltd 2017-09-28
Novartis–Univ California: drug discovery technology, 201709– collab establishment of Novartis-Berkeley Center for Proteomics & Chemistry Technologies 2017-09-28
Orgentec–Streck: laboratory equipment, 201709– distribution of Streck cell stabilisation + molecular products by Orgentec SASA in France 2017-09-28
Merlin Diagnostika–Bruker Corp: investment, 201709 acquisition €na by Bruker 2017-09-26
Sonic Healthcare–Bruker Corp: mass spectrometer, 201709 supply existent MLB is long-term user of MALDI Biotyper system 2017-09-26
Atriva Therapeutics–InSynchrony Ventures: investment, 201709 seed financing round 2nd tranche incl new investor InSynchrony Ventures 2017-09-21
Atriva Therapeutics–SEVERAL: investment, 201709 seed financing round 2nd tranche incl new investor InSynchrony Ventures 2017-09-21
Humabs BioMed–Vir Biotechnology: investment, 201709 acquisition of Humabs by Vir 2017-09-21
Juno Therapeutics–Celgene: investment, 201709 private placement $31.1m to Celgene with 758k shares at $41/share 2017-09-20
Juno Therapeutics–SEVERAL: investment, 201709 public offering $250.1m+$37.515m with 6.1m+915k shares at $41/share 2017-09-20
Nabriva–W2O Group: public relations, 201709 service existent PR by Pure Communications 2017-09-20
BioNTech–Akampion: public relations, 201709 service existent by Akampion 2017-09-19
Axiogenesis–Pluriomics: investment, 201709 merger into Ncardia 2017-09-18
Bruker Corp–Bioinformatics Solutions: mass spectrometry software, 201709 collab existent using PEAKS Studio s/w for MS-based proteomics 2017-09-18
Bruker Corp–Max Planck: mass spectrometry, –201709 collab developm of PASEF technology for timsTOF Pro MS for proteomics with Matthias Mann 2017-09-18
High-Tech Gründerfonds–Evonik: investment, 201709 investment existent in HTGF III fund 2017-09-18
Nabriva–SEVERAL: investment, 201709 public offering $80m+$12m with 9.4m+1.4m ordinary shares at $6/share 2017-09-18
Numaferm–Evonik: investment, 201709 Evonik Venture Capital joins €7-digit seed financing round 2017-09-18
ThromboGenics–Novartis: investment, 201709–201801 equity investment €10m by Novartis after termination of Jetrea agreement 2017-09-18
Tolremo Therapeutics–SEVERAL: investment, 201709 seed financing round CHF2.4m 2017-09-18
BioBridges–Adecco: investment, 201709 acquisition €na of BioBridges by Adecco Group 2017-09-14
Evotec–MaRS Innovation: drug discovery, 201709– collab partnership LAB150 for early-stage projects out of Canadian academic institutions 2017-09-14
Ginkgo Bioworks–Bayer: investment, 201709– founding joint venture firm with $100m Series A from Ginkgo + BLSC + Viking Global Investors 2017-09-14
Ginkgo Bioworks–SEVERAL: investment, 201709– founding joint venture with Bayer with $100m Series A from Ginkgo + BLSC + Viking Global Investors 2017-09-14
Ginkgo Bioworks–Viking Global Investors: investment, 201709– founding Ginkgo/Bayer joint venture with $100m Series A from Ginkgo + BLSC + Viking 2017-09-14
Flagship Pioneering–Lipotype: lipid analysis, 201709c supply service lipid anaylsis for Flagship VentureLabs 2017-09-13
Genenta Science–SEVERAL: investment, 201709 financing round Series B €7m 2017-09-13
GreenLight Biosciences–SEVERAL: investment, 201709 financing round Series D $18m led by Fall Line Capital 2017-09-13
Sophia Genetics–SEVERAL: investment, 201709 financing round Series D $30m led by Balderton Capital 2017-09-13
Bayer–Berkeley Lights: cell line development, 201709– collab using Beacon platform for cell line development + antibody discovery 2017-09-12
DNA Script–Idinvest Partners: investment, 201711 financing round Series A totalling €11m incl existing investor Idinvest Partners 2017-09-12
DNA Script–Illumina: investment, 201711 financing round Series A totalling €11m incl lead + new investor Illumina Ventures 2017-09-12
DNA Script–Kurma: investment, 201711 financing round Series A totalling €11m incl existing + seed investor Kurma Partners 2017-09-12
DNA Script–Merck (DE): investment, 201711 financing round Series A totalling €11m incl new investor Merck Ventures BV 2017-09-12
DNA Script–SEVERAL: investment, 201711 financing round Series A €11m led by Illumina Ventures 2017-09-12
DNA Script–Sofinnova: investment, 201711 financing round Series A totalling €11m incl existing + seed investor Sofinnova Partners 2017-09-12
Ayoxxa–MC Services: public relations, 201709 service existent by MC Services AG 2017-09-11
Epigenomics–Cathay Fortune: credit, 201709 convertible bonds €7.1m net €6.5m to Cathay Fortune 2017-09-08
BRAIN–Hopp Group: investment, 201709 capital increase 1.641m new shares placed with new investor DAH Beteiligungs GmbH 2017-09-07
BRAIN–Hopp Group: investment, 201709 capital increase €28m with 1.641m new shares at €18.055 to new investor DAH Beteiligungs GmbH 2017-09-07
Rigontec–Merck (US): investment, 201709– acquisition €115m cash upfront + €349m milestones 2017-09-06
Amal Therapeutics–BioMedPartners: investment, 201709 financing round Series B first closing totalling €8m incl co-lead investor BioMedPartners 2017-09-05
Amal Therapeutics–Boehringer: investment, 201709 financing round Series B first closing totalling €8m incl co-lead investor BIVF 2017-09-05
Amal Therapeutics–Helsinn: investment, 201709 financing round Series B first closing totalling €8m incl co-lead investor Helsinn Investment Fund 2017-09-05
Amal Therapeutics–High-Tech Gründerfonds: investment, 201709 financing round Series B first closing totalling €8m incl co-investor HTGF 2017-09-05
Amal Therapeutics–Schroders: investment, 201709 financing round Series B first closing totalling €8m incl co-investor Schroder Adveq 2017-09-05
Amal Therapeutics–SEVERAL: investment, 201709 financing round Series B first closing €8m co-led by BIVF + BioMedPartners + Helsinn 2017-09-05
Amal Therapeutics–VI Partners: investment, 201709 financing round Series B first closing totalling €8m incl co-investor VI Partners 2017-09-05
Immunic–SEVERAL: investment, 201709 financing round Series A extension €10m led by LSP bringing total Series A to €31.7m 2017-09-05
Metabolomic Discoveries–Metabolon: investment, 201709 acquisition €na of Metabolomic Discoveries GmbH by Metabolon Inc 2017-09-05
Pharnext–MC Services: public relations, 201709 service existent investor relations Europe by MC Services 2017-09-05
Boehringer–Allcyte: drug discovery, 201709– collab using Pharmacoscopy ex vivo drug response profiling platform for BI oncology candidates 2017-09-04
Amcure–Germany (govt): grant, 201708 BMBF research grant €1.75m to advance clinical lead candidate AMC303 2017-08-31
Angiex–Merck (DE): drug development services, 201708– supply BioReliance End-to-End Solutions for developm of ADC therapy of Angiex Inc 2017-08-29
Apeiron–EU (govt): credit, 201708– EIB EFSI loan €25m to support developm of cancer drugs 2017-08-28
Kite Pharma–Gilead: investment, 201708–201710 acquisition $11.9b cash tender offer $180/share 2017-08-28
Natrix Separations–Merck (DE): investment, 201708– acquisition €na of Natrix Separations by Merck ANNOUNCED 2017-08-28
Aurealis Pharma–SEVERAL: investment, 201708 financing round Series A CHF5.6m from private investors + Finnvera + Tekes 2017-08-25
Novartis–Xoma: IL-1 beta antibodies, 201708– license $26m upfront + $5m investment + milestones + royalties ww rights to gevokizumab + IL-beta Ab IP 2017-08-25
Labfolder–Germany (govt): business development, 201708– supply service support in US with German Accelerator Life Sciences programme 2017-08-24
Macrophage Pharma–Merck (DE): investment, 201708 financing round Series A extension with new investor Merk Ventures 2017-08-23
next pagenext page 1 2 3 ... 9 10 11 ... 54 55 56  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px

» top